Dorsey & Whitney Trust CO LLC Makes New Investment in Fresenius Medical Care AG (NYSE:FMS)

Dorsey & Whitney Trust CO LLC purchased a new position in shares of Fresenius Medical Care AG (NYSE:FMS) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,541 shares of the company’s stock, valued at approximately $216,000.

Other large investors also recently made changes to their positions in the company. Callan Family Office LLC purchased a new position in shares of Fresenius Medical Care during the 4th quarter worth $502,000. Callan Capital LLC purchased a new position in shares of Fresenius Medical Care during the 4th quarter worth $297,000. Sanctuary Advisors LLC purchased a new position in shares of Fresenius Medical Care during the 4th quarter worth $983,000. ABC Arbitrage SA acquired a new stake in shares of Fresenius Medical Care during the 4th quarter worth $4,215,000. Finally, Verition Fund Management LLC acquired a new stake in shares of Fresenius Medical Care during the 3rd quarter worth $237,000. Hedge funds and other institutional investors own 8.37% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on FMS. Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a report on Monday, December 2nd. Truist Financial upped their price objective on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Finally, StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th.

Fresenius Medical Care Stock Up 2.6 %

Shares of NYSE FMS opened at $24.37 on Wednesday. Fresenius Medical Care AG has a 12-month low of $17.93 and a 12-month high of $25.25. The company has a market cap of $14.30 billion, a P/E ratio of 20.14, a P/E/G ratio of 0.76 and a beta of 0.99. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The stock has a fifty day moving average price of $23.58 and a 200 day moving average price of $22.12.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.